Key Highlights
- Second-quarter Revenue at Bending Spoons surged 126% to USD 704.2 million, though organic growth was a mere 3%, and the company is due before the open on November 20, 2026.
- Elastic's consensus of USD 0.81 in EPS and USD 486.7 million in revenue falls within its guided USD 0.80 to 0.82 and USD 486 million to 487 million, with a report listed after the close on November 19, 2026.
- Ahead of its November 19, 2026 report and after a second quarter of flat sales, Globant guided to USD 1.43 to 1.53 of adjusted EPS on USD 607 million to 615 million of revenue.
- A calendar lists Endava for November 19, 2026, but on October 28 it warned of a missed filing deadline and pulled guidance, and Formula Systems has no confirmed date either.
Elastic (NYSE:ESTC): Expectations Fall Inside a Narrow Guided Band
Fiscal second-quarter 2027 results, covering the three months to October 31, 2026, are listed for Elastic (NYSE:ESTC) after the close on Thursday, November 19, 2026. Only single-source coverage supplies that date, and no company notice was located. The analyst view is USD 0.81 of non-GAAP EPS on USD 486.7 million of revenue, and both land inside what Elastic (NYSE:ESTC) guided: USD 0.80 to USD 0.82 for EPS and USD 486 million to USD 487 million for revenue. That tight band leaves little room for surprise at Elastic (NYSE:ESTC). In the prior quarter, sales of USD 478.1 million advanced 15.1% and cleared a USD 469.7 million consensus, after which full-year revenue guidance went up to USD 1.998 billion to USD 2.010 billion. A consensus for EPS in that quarter was not verified. Current remaining performance obligations deserve the closest look at Elastic (NYSE:ESTC), having expanded 20% in constant currency in each of two straight quarters, even as net expansion dipped from 112% to 111%. Per published coverage, the stock has lost about 16% since. Investors in Elastic (NYSE:ESTC) will want to see that metric hold. A cRPO slowdown is the specific risk for Elastic (NYSE:ESTC).
Globant (NYSE:GLOB): Guided Range Surrounds a Quarter of Flat Sales
A company announcement confirms that Globant (NYSE:GLOB) will post third-quarter 2026 results after the close on November 19, 2026, along with a video call and live Q&A. The date is firm for Globant (NYSE:GLOB). Guidance calls for adjusted EPS of USD 1.43 to 1.53 alongside USD 607 million to 615 million of revenue. One calendar lists EPS of 1.48, which is precisely the middle of that range (calculated), and no published consensus was verified for Globant (NYSE:GLOB). Last quarter revenue of USD 614.4 million was level with USD 614.2 million, whereas adjusted EPS fell from USD 1.53 to USD 1.40 and adjusted Margin from 15.0% to 13.2%. A consensus for that quarter was not located, so no beat or miss is stated. At Globant (NYSE:GLOB), watch annual Recurring Revenue from Glob.AI, which stands at USD 52.8 million against a year-end 2026 goal of at least USD 110 million. The risk is that flat Demand leaves margin under the guided 13.5% to 14.5% at Globant (NYSE:GLOB). Margin is the swing Factor for Globant (NYSE:GLOB).
Endava (NYSE:DAVA): The Company Has Not Backed Its Calendar Date
Endava (NYSE:DAVA) sits on a calendar for November 19, 2026, after the close, covering the fiscal fourth quarter to June 30, 2026. The company, however, said on October 28, 2026 that the November 2 deadline for its Annual Report would be missed and that timing would follow, and no new date turned up. With earlier fourth-quarter and full-year guidance withdrawn, the 0.1 calendar EPS is not used as a consensus for Endava (NYSE:DAVA). Per single-source coverage of the consensus, third-quarter fiscal 2026 revenue of GBP 178.5 million came in under the GBP 183.87 million expected. Adjusted EPS of GBP 0.05 did better than the GBP 0.02 forecast. Both periods are now among those Endava (NYSE:DAVA) will restate. How large the restatement turns out to be is the metric to watch, since revenue is expected to shrink by about 2% to 4% of fiscal 2025 revenue. Roughly GBP 55 million of cash, lender covenant talks and expected material weaknesses in internal control are the risks for Endava (NYSE:DAVA). A confirmed date is the first need at Endava (NYSE:DAVA). The restatement clouds every figure at Endava (NYSE:DAVA).
Formula Systems (NASDAQ:FORTY): A Listed Date With No Estimate Attached
The calendar lists Formula Systems (NASDAQ:FORTY) for third-quarter 2026 results on November 19, 2026, giving no time and no EPS estimate. A company notice was not found, and last year's report arrived on November 20, 2025, so the date remains unconfirmed. Neither EPS nor revenue has a published consensus, which makes the quarterly trend the reference for Formula Systems (NASDAQ:FORTY). The Israeli holding company's subsidiaries offer IT services and software. Second-quarter revenue climbed 29.8% to USD 782.4 million and Operating Income gained 41.3%, reaching USD 71.6 million. Diluted EPS of USD 1.47 compares with USD 0.95 on a restated base, since Sapiens now counts as a discontinued operation. Nobody verified the consensus for that quarter, so no beat or miss is stated. Operating margin, about 9.2% last quarter (calculated), is the metric to watch at Formula Systems (NASDAQ:FORTY). Matrix IT, which grew just 6.3%, is a dependency for Formula Systems (NASDAQ:FORTY). Shekel translation and the absence of formal guidance round out the risks for Formula Systems (NASDAQ:FORTY). The trend is the only guide at Formula Systems (NASDAQ:FORTY).
Bending Spoons (NASDAQ:BSP): A Guided Range Surrounding Consensus
Bending Spoons (NASDAQ:BSP) announced on its own that it will report third-quarter 2026 results ahead of the U.S. open on November 20, 2026, with a call and webcast. A single-source report puts revenue consensus near USD 739.4 million, which falls inside the USD 733 million to USD 745 million guide at Bending Spoons (NASDAQ:BSP). Bending Spoons (NASDAQ:BSP) has the most precise range of the five. The USD 0.30 EPS on the calendar has an unverified basis. For the prior quarter, adjusted EPS of USD 0.46 stood against a published USD 0.27 consensus, and revenue of USD 704.2 million stood against roughly USD 684.4 million, growth of 126% with organic growth of only 3%. Adjusted operating income guided at USD 380 million to USD 400 million would mean a margin of roughly 52% to 54% (calculated). Whether organic growth moves past 3% is the metric to watch at Bending Spoons (NASDAQ:BSP). The risks for Bending Spoons (NASDAQ:BSP) are USD 4.09 billion of net Debt and integrating acquired products. Acquisitions drove most of the growth at Bending Spoons (NASDAQ:BSP). Bending Spoons (NASDAQ:BSP) will be measured on organic momentum, not acquisitions.
Where Things Stand
It depends, as none of the five has reported and just one has posted a 126% jump. Acquisitions drove most of that growth at Bending Spoons (NASDAQ:BSP), where organic growth was 3%. The guidance at Elastic (NYSE:ESTC) brackets expectations, so its reaction may hinge on cRPO. Globant (NYSE:GLOB) looks alike, with margin and Glob.AI in focus. Endava (NYSE:DAVA) has a date that nobody has confirmed. Formula Systems (NASDAQ:FORTY) shares that problem, and none of these figures implies a result. Next come company date notices and the November 19 and 20, 2026 releases.






Please wait processing your request...